Introduction
============

Nowadays, the use of dental implants has become an accepted treatment modality in clinical dentistry in both fixed and removable solutions. [@JR_1] [@JR_2] [@JR_3] [@JR_4] [@JR_5] Over the years, implant designs and surgical techniques have undergone significant improvements, resulting in current survival rates surpassing 95% after 5 years of follow-up. [@JR_6]

Today, clinical research is focusing on shorter and less invasive procedures. Different implant designs, [@JR_7] [@JR_8] as well as, placement and loading protocols are currently used to shorten treatment times and decrease the amount of surgical interventions, enabling clinicians to choose between a one-(nonsubmerged) and a two-stage (submerged) approach. Against different loading protocol, it has been showed that the submerged technique is not a prerequisite for osseointegration, [@JR_9] even if one-stage implant placement might be at a slightly higher risk of early failures. Primary implant stability is still considered to be a prerequisite for the long-term success of an implant-supported prosthesis. [@JR_10] Primary stability depends mainly on the macro- and micro-design of the implant including the functional length, besides surgical technique and properties of local bone. [@JR_11] [@JR_12]

The more their applications increase, the greater the clinical interest becomes in the implants integrating quickly with the bone to be functional. In the last decade, there was an ongoing effort to improve the interface between bone and implant to speed up the process of osseointegration and improve its quality. [@JR_13] These efforts have been concentrating in improving this interface chemically (by incorporating inorganic phases on or into the titanium oxide layer) or physically (by increasing the level of roughness). [@JR_14]

Different techniques have been utilized to alter the surface topography of dental implants. These techniques are usually applying either additive or subtractive concepts. Long-term studies showed that additive surfaces have a higher incidence of complications which was attributed to the delamination of the thick HA layer and to the uncontrolled rate of dissolution of deposited phases. [@JR_15] Consequently, subtractive surfaces have become more popular by clinicians.

Although shorter healing period was presented in many experimental and clinical studies using sandblasted and acid-etched (SLA) surfaces, [@JR_16] [@JR_17] modification of this surface seems to presents a stronger bone response than its predecessor. [@JR_18] [@JR_19]

The purpose of this split-mouth randomized controlled trial was to compare early implant failure and implant stability of one-stage Hiossen ET III implants with its new hydrophilic (NH) surface, compared with Hiossen ET III implants with the well-known SA surface. The null hypothesis was that there is no difference between groups. The null hypothesis was tested against the alternative hypothesis of differences between them. The following trial was reported according to the STROBE statement.

Materials and Methods
=====================

This study was designed as a split-mouth, randomized controlled trial of parallel groups with two arms, conducted at one center, between November 2017 and May 2018. The protocol was registered in the [clinicaltrial.gov](clinicaltrial.gov) (NCT03649100). The 2013 Helsinki declaration was adhered too. The study was performed after approval was received from the Institutional Review Board of the Aldent University, Tirana, Albania (3/2018). Surgical and prosthetic procedures were performed by one expert clinician.

Any healthy patients, aged 18 years or older, required at least two implants to be rehabilitated with a fixed implant-supported restoration, with a full mouth bleeding and full mouth plaque index ≤ 25%, with a sufficient bone to allow placement of at least 11.5 mm-long implants, and bone width of at least 6 to 8 mm for the placement of a regular platform Hiossen ET III implant (Deutsche Osstem GmbH, Eschborn, Germany) were included in this study.

The exclusion criteria were as follows: positive medical findings (such as stroke, recent cardiac infarction, severe bleeding disorder, uncontrolled diabetes, or cancer), psychiatric therapy, pregnancy or nursing, smoking \> 10 cigarettes per day, insertion torque \< 35 Ncm, untreated periodontitis, acute and chronic infections of the adjacent tissues or natural dentition, previous radiotherapy of the oral and maxillofacial region within the past 5 years, postextractive implants (at least 3 months after tooth extraction), absence of teeth in the opposing jaw, severe clenching or bruxism, severe maxillomandibular skeletal discrepancy, and poor oral hygiene.

Patients were informed about the clinical procedures, the materials to be used, the benefits, potential risks and complications, as well as any follow-up evaluations required for the clinical study. Patients had to sign the informed consent before including in the study.

A single dose of antibiotic (2 g of amoxicillin and clavulanic acid or clindamycin 600 mg if patients were allergic to penicillin) was administered prophylactically 1 hour before surgery. Patients rinsed with 0.2% chlorhexidine for 1 minute. Local anesthesia will be induced using a 4% articaine solution with epinephrine 1:100 000 (Ubistesin; 3M Italia, Milan, Italy). Implants were placed in the planned anatomic sites using a flapless or a mini-flap approach ( [Figs. 1](#FI17-1){ref-type="fig"} [2](#FI17-2){ref-type="fig"} ). Bone density was assessed, according to the Lekholm and Zarb classification, during the drilling phase, based on the clinician\'s experience and judgment. Implant site was prepared simultaneously, according to the drilling protocol recommended by the manufacturer. SA surface implants (SA group) or SA surface implants with a newly developed bioabsorbable apatite nanocoating (NH group) were randomized after implant site preparation, immediately before implant placement. Implants used in every group were identical except for the surface treatment. After implant placement, the insertion torque values of the implants were measured and recorded during surgery using a surgical unit (iChiroPro, Bien Air, Italy). Then, a smart peg (Type 47 cod. 100478, Osstell, Gothenburg, Sweden) was connected to the implants, and the implant stability quotient (ISQ) was measured and recorded using the Osstell Mentor device (Osstell), at implant placement, and every week up to 8 weeks after implant placement.

![Computer-assisted template-based implant placement (Osstem OneGuide Kit, Osstem, Seoul, South Korea): occlusal view.](10-1055-s-0039-1688737_00017_01){#FI17-1}

![Digital impression (3M true definition scanner, 3M Italia): occlusal view.](10-1055-s-0039-1688737_00017_02){#FI17-2}

Implants were placed according to a one-stage protocol and measured every week up to 8 weeks. Then implants were measured again 12 weeks after implant placement. In case of ISQ value \<55 or in case of implant mobility, healing abutment was replaced with a cover screw and the implant was left to heal submerged for at least 6 weeks.

Postsurgical analgesic treatment was performed with ibuprofen 600 mg, which was administered twice a day for 2 days after the surgery, and later on, if required. Periapical radiographs were taken with a customized holder at implant placement, at the definitive prosthesis delivery, and then yearly. Two to three months after implants placement patients receive single screw-retained restorations ( [Figs. 3](#FI17-3){ref-type="fig"} [](#FI17-4){ref-type="fig"} [5](#FI17-5){ref-type="fig"} [6](#FI17-6){ref-type="fig"} [7](#FI17-7){ref-type="fig"} [8](#FI17-8){ref-type="fig"} [9](#FI17-9){ref-type="fig"} ).

![Periapical radiograph at implant placement.](10-1055-s-0039-1688737_00017_03){#FI17-3}

![Definitive, single, screw-retained crowns: occlusal view. The distal implant was left to heal submerged.](10-1055-s-0039-1688737_00017_04){#FI17-4}

![Definitive, single, screw-retained crowns: lateral view. The distal implant was left to heal submerged.](10-1055-s-0039-1688737_00017_05){#FI17-5}

![Periapical radiograph at definitive crowns delivery. The distal implant was left to heal submerged.](10-1055-s-0039-1688737_00017_06){#FI17-6}

![Definitive restorations at 6-month of follow-up: occlusal view.](10-1055-s-0039-1688737_00017_07){#FI17-7}

![Definitive restorations at 6-month of follow-up: lateral view.](10-1055-s-0039-1688737_00017_08){#FI17-8}

![Periapical radiograph at 6-month of follow-up.](10-1055-s-0039-1688737_00017_09){#FI17-9}

The outcome measures were implant and prosthetic survival rates, any biological or mechanical complications at implants that occurred during the entire observation period.

Success rates of the implants and prostheses were evaluated by an independent assessor (EX). An implant was considered a failure if it presented mobility, assessed after the osseointegration period by tapping or rocking the implant head with the metallic handles of two instruments, progressive marginal bone loss or infection, or any mechanical complications rendering the implant unusable, although still mechanically stable in the bone. A prosthesis was considered a failure if it needed to be replaced with another prosthesis.

Biological (pain, swelling, suppuration, etc.) and/or mechanical (screw loosening, fracture of the framework, the veneering material, etc.) complications occurred during the follow-up period. Complications were evaluated and treated by the same surgeon (MT).

Insertion torque was recorded at implant placement by the same surgeon (MT) using the iChiropro surgical unit (Bien-Air, Bienne, Switzerland).

ISQ values were recorded each week up to 8 weeks, and then, after 12 weeks, using resonance frequency analysis (Osstell Mentor device, Osstell, Gothenburg, Sweden), according to a previously published study. [@JR_2] A blind outcome assessor collected the data (EX).

A pregenerated random list, consisting of a randomized sequence of consecutive numbers matching the two different procedures within group A or group B, was created using random number generator pro 1.91 for Windows (Segobit Software; [www.segobit.com](www.segobit.com) ). Opaque envelopes containing the randomization codes were sequentially numbered and sealed. According to a pregenerated list, an independent consultant, not previously involved in the trial, prepared all the envelopes and then opened immediately after implant sites preparation. Site one was defined the site with the lower sextant number and the most mesial. Patient data were collected in an Excel spreadsheet (Microsoft) that reflected the parameters in the patient records. The data were exported into SPSS software for Mac OS X (version 22.0; SPSS, Chicago, Illinois, United States), for the statistical analysis. Descriptive analysis was performed for numeric parameters using means and standard deviations (95% confidence interval). Comparison between groups was made by unpaired *t* -test, while the comparison between each follow-up will be made by paired *t* -tests to detect any change during the follow-up. Complications and failures were compared using the Fisher\'s exact test. All statistical comparisons were two-tailed and conducted at the 0.05 level of significance. The patient was used as the statistical unit of analysis.

Results
=======

A total of 14 patients (13 females and 1 male, with a men age of 58.3 ± 11.9) were screened as they were consecutively enrolled for the trial. All patients were originally treated according to the allocated interventions and no patient dropped out. A total of 28 implants (14 with SA surface and 14 with SA surface with the newly developed bioabsorbable apatite nanocoating) were placed. Four patients were rehabilitated in the mandible and 10 in the maxilla. Four-month after definitive prosthesis delivery, no implant and no prosthesis failed. Two weeks after placement, two Hiossen ET III SA implants showed a small mobility with ISQ values lower than 55 (49 and 51, respectively) while no complications were reported in the NH group. Nevertheless, no statistically significant difference was reached ( *p* = 0.4815). In both the implants, the healing abutments were replaced with a cover screw and the implants were left to heal submerged for 6 weeks.

The overall insertion torque ranged between 35.0 and 45.0 Ncm (mean of 41.5 ± 3.3 \[39.7--43.5\] Ncm in the SA group and 41.4 ± 3.2 \[40.3--43.9\] Ncm in the NH group). The difference was not statistically significant ( *p* = 0.936).

The ISQ values between groups and within time were reported in [Table 1](#TB_1){ref-type="table"} . Although there is no statistically significant difference between groups, NH implants did not show physiological ISQ decrease between 2nd and 4th week after implant placement, showing a more even pattern of ISQ values ( [Fig. 10](#FI17-10){ref-type="fig"} ). At the 2nd week, Hiossen ET III implants with its NH group showed a mean ISQ value of 77.1 ± 4.6 (73.4--78.6) compared with 72.9 ± 11.5 (71.5--84.5) of the Hiossen ET III implants with the well-known SA surface. The difference was not statistically significant (4.2 ± 12.1 \[--6.3--7.3\]; *p* = 0.258). Compared with the baseline (implant placement), at the last follow-up examination the NH implants showed a little improvement in the ISQ values (76.7 ± 6.0 \[71.6--78.4\] compared with 79.2 ± 3.9 \[77.8--82.2\]; difference 2.5 ± 4.3 \[0.1--4.9\]; *p* = 0.246) compared with the SA implants (78.0 ± 5.9 \[76.2--82.8\] compared with 78.1 ± 5.1 \[75.9--81.6\]; difference 0.2 ± 2.3 \[--1.1--1.6\]; *p* = 0.941). The differences were not statistically significant.

![Development of the implant stability quotient values in the sandblasted and acid-etched and new hydrophilic surface group during the 8 weeks of study period. ISQ, implant stability quotient; NH, new hydrophilic; SA, sandblasted and acid-etched.](10-1055-s-0039-1688737_00017_010){#FI17-10}

###### Implant stability quotient value between groups

  Weeks   SA ( *n* = 14)                  NH ( *n* = 14)            *p-* Value
  ------- ------------------------------- ------------------------- ------------
  0       77.9 ± 5.9 (76.2--82.8)         76.7 ± 5.6 (71.6--78.4)   0.611
  1       77.2 ± 5.6 (76.4--82.6)         77.4 ± 5.3 (73.3--79.2)   0.941
  2       72.9 ± 11.5 ^a^ (71.5--84.5)    77.1 ± 4.6 (73.4--78.6)   0.258
  3       76.9 ± 4.6 ^a^ (72.9--78.1)     77.3 ± 4.7 (74.8--80.2)   0.863
  4       78.4 ± 3.6 ^a^ (76.0--80.0)     77.5 ± 4.3 (75.1--79.9)   0.582
  5       78.6 ± 3.1 ^a^ (76.3--79.8.8)   77.8 ± 4.1 (75.7--80.3)   0.604
  6       78.7 ± 3.9 ^a^ (76.0--80.5)     78.0 ± 4.2 (75.6--80.4)   0.694
  8       78.1 ± 5.1 (75.9--81.2)         79.2 ± 3.9 (77.8--82.2)   0.576

Discussion
==========

This split-mouth randomized controlled trial was designed to evaluate if the new SA surface with a newly developed bioabsorbable apatite nanocoating has any influence on early success rate and implant stability during osseointegration period. The results of the present study have not shown any statistically significant difference in ISQ measurements even though NH implants did not show physiological ISQ decrease between 2nd and 4th week after implant placement, showing a more even pattern of ISQ values.

Primary stability and absence of micromovements are two of the main prerequisites for obtaining a stable osseointegration and the achievement of long-term high-success rates for dental implants. [@JR_20] [@JR_21] In fact, if primary stability is absent during the early healing period, implant mobility can occur, and this could lead to a soft-tissue interface promoting its failure. [@JR_22] [@JR_23] In the last decades to reduce the risk of soft-tissue encapsulation, it has been recommended that implants be kept load-free during a healing period of 3 to 4 months in mandibles and 6 to 8 months in maxillae. [@JR_24]

Nowadays, the more implants are used in clinical routine, the greater the clinical interest becomes in the implants integrating quickly with the bone to be functional. An ongoing effort to improve the interface between bone and implant surface to speed up the process of osseointegration has been proposed by researcher and dental implant companies.

Commonly, implant surface roughness is divided, depending on the dimension of the measured surface features, into macro-, micro-, and nanoroughness. Typically, these different roughness features are related to distinct effects during wound healing and osseointegration. [@JR_25] Titanium nanostructures have been created by different approaches such as oxidative nanopatterning by acid etching in mixtures of sulfuric acid and hydrogen peroxide, by exposing titanium samples to flowing synthetic air, electrochemically by anodic oxidation, by processing samples after acid etching under protective gas and storing them in saline, by plasma etching, or by physical vapor deposition techniques. [@JR_26]

It is well known that roughness increases implant osseointegration, and several implant types are sandblasted and/or acid-etched to increase their surface texture. [@JR_22] Nevertheless, surfaces coated with hydroxyapatite (HA) were reported to have a higher incidence of complications, [@JR_15] even if evidence for the influence of the implant surface characteristics as a risk indicator for peri-implantitis is very limited. [@JR_27]

Vice versa, the nanometer roughness plays an important role in the adsorption of proteins, adhesion of osteoblastic cells, and thus the rate of osseointegration. [@JR_28] In fact, the deposition through dip coating of nanocomposite (HA-ZrO ~2~ -Al ~2~ O ~3~ ) on titanium substrate showed the highest adhesion strength compared with the HA coatings. [@JR_29] Furthermore, Schwarz et al showed that angiogenesis was enhanced on hydrophilic surfaces during early stages of osseointegration. [@JR_30] [@JR_31] Actually, fast vascularization seems beneficial for bone formation because osteogenic cells have been observed to arise from pericytes adjacent to small blood vessels. [@JR_21] [@JR_32]

In the present study, implants with the hydrophilic surface seem to avoid the ISQ drop during the remodeling phase allowing accordingly benefits in immediate loading, poor bone quality, postextractive, smoking, and immunosuppression disease. Looking for a deeper understanding of the different bioresponses to SLActive versus SLA, a very recent study found thinner carbon contamination films on SLActive (0.8 nm) compared with SLA (1.6 nm) suggesting an impact of the different contamination films on the blood response, leading to accelerated osseointegration. [@JR_33]

In a review of the available human studies, Wennerberg et al have found little clinical evidence so far to clearly state a preference for SLActive over SLA implant. [@JR_34] In a split-mouth study, SLActive implants were compared with SLA implants with early loading protocols in irradiated patients. One-hundred two implants were placed in 20 patients in both jaws. At 1-year follow-up, there was a high survival rate (100% for SLActive vs. 96% for SLA implants) and low crestal bone loss \< 0.4 mm in both groups with no significant difference. [@JR_35]

Conclusions
===========

High ISQ values were found in both groups at each time point. NH implants are a viable alternative to SA surface, as they seem to avoid the ISQ drop during the remodeling phase. It can be beneficial in immediate loading, poor bone quality, postextractive, smoking, and immunosuppression. Further trials with larger sample size and longer follow-up are needed to confirm these preliminary results.
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